Shenzhen Edge Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	86.04	119.81	155.32
Short-Term Investments	-	107.2	-
Trading Asset Securities	727.81	876.5	1,067
Cash & Short-Term Investments	813.86	1,104	1,222
Cash Growth	-26.25%	-9.72%	-
Accounts Receivable	226.53	55.3	17.09
Other Receivables	-	20.37	16.53
Receivables	226.53	75.66	33.62
Inventory	136.11	73.71	77.16
Other Current Assets	157.86	11.9	17.3
Total Current Assets	1,334	1,265	1,350
Property, Plant & Equipment	42.05	92.3	88.69
Long-Term Investments	0.13	-	103.69
Other Intangible Assets	0.09	1.16	2.98
Long-Term Accounts Receivable	4	-	-
Other Long-Term Assets	5.12	2.49	9.94
Total Assets	1,386	1,361	1,556
Accounts Payable	135.47	8.3	5.88
Accrued Expenses	-	32.83	34.87
Current Portion of Leases	4.25	7.7	8.01
Current Unearned Revenue	7.73	5.82	4.62
Other Current Liabilities	16.99	32.19	24.16
Total Current Liabilities	164.45	86.84	77.55
Long-Term Leases	5.64	10.33	18.72
Long-Term Unearned Revenue	16.94	3.61	21.04
Total Liabilities	187.03	100.77	117.3
Common Stock	360	360	360
Additional Paid-In Capital	-	1,556	1,556
Retained Earnings	-	-721.12	-502.62
Comprehensive Income & Other	838.71	64.77	24.65
Shareholders' Equity	1,199	1,260	1,438
Total Liabilities & Equity	1,386	1,361	1,556
Total Debt	9.89	18.03	26.73
Net Cash (Debt)	803.96	1,085	1,196
Net Cash Growth	-25.94%	-9.21%	-
Net Cash Per Share	2.27	3.02	3.32
Filing Date Shares Outstanding	348.86	387.72	360
Total Common Shares Outstanding	348.86	360	360
Working Capital	1,170	1,178	1,273
Book Value Per Share	3.44	3.50	4.00
Tangible Book Value	1,199	1,259	1,435
Tangible Book Value Per Share	3.44	3.50	3.99
Machinery	-	72.37	47.06
Leasehold Improvements	-	22.37	15.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.